Literature DB >> 24134186

Galectin-7, induced by cis-urocanic acid and ultraviolet B irradiation, down-modulates cytokine production by T lymphocytes.

Takashi Yamaguchi1, Kana Hiromasa, Rieko Kabashima-Kubo, Manabu Yoshioka, Motonobu Nakamura.   

Abstract

Urocanic acid (UCA) is an epidermal chromophore that undergoes trans to cis isomerization after UVB irradiation. cis-UCA is a potent inhibitor of cutaneous acquired immunity. The aim of this study was to explore the genes, which are upregulated by cis-UCA in normal human epidermal keratinocytes (NHEK) and investigated its role in vitro using human T-lymphocyte cell line, Jurkat cells. DNA microarray analysis and real-time PCR investigation revealed that cis-UCA, not trans-UCA, increased the expression of a gene encoding a β-galactoside-binding lectin, galectin-7, LGALS7B. Immunohistochemical study demonstrated that galectin-7 was highly expressed in the epidermis in the patients with actinic keratosis. Galectin-7 administration upregulated apoptosis and inhibited the expression of interleukin-2 (IL2) and interferon-γ (IFNG) mRNA in Jurkat cells. Taken together, galectin-7 may play important roles in downregulating the functions of T lymphocytes after UVB irradiation and can be developed into novel immunosuppressive therapies for inflammatory skin diseases.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  UVB; actinic keratosis; apoptosis; cis-urocanic acid; galectin-7

Mesh:

Substances:

Year:  2013        PMID: 24134186     DOI: 10.1111/exd.12268

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  14 in total

Review 1.  Towards molecular mechanisms regulating the expression of galectins in cancer cells under microenvironmental stress conditions.

Authors:  Alexander V Timoshenko
Journal:  Cell Mol Life Sci       Date:  2015-08-06       Impact factor: 9.261

2.  Expression of galectin-7 in vulvar lichen sclerosus and its effect on dermal fibroblasts.

Authors:  Yi Zhao; Shanshan Zhao; Hui Li; Xin Qin; Xin Wu
Journal:  Oncol Lett       Date:  2018-06-04       Impact factor: 2.967

3.  Expression and functions of galectin-7 in ovarian cancer.

Authors:  Marilyne Labrie; Maria Claudia Vladoiu; Andrée-Anne Grosset; Louis Gaboury; Yves St-Pierre
Journal:  Oncotarget       Date:  2014-09-15

4.  Identification of (poly)phenol treatments that modulate the release of pro-inflammatory cytokines by human lymphocytes.

Authors:  Christopher T Ford; Siân Richardson; Francis McArdle; Silvina B Lotito; Alan Crozier; Anne McArdle; Malcolm J Jackson
Journal:  Br J Nutr       Date:  2016-03-17       Impact factor: 3.718

5.  Suppression of experimental autoimmune encephalomyelitis by ultraviolet light is not mediated by isomerization of urocanic acid.

Authors:  Amy A Irving; Steven J Marling; Lori A Plum; Hector F DeLuca
Journal:  BMC Neurosci       Date:  2017-01-05       Impact factor: 3.288

Review 6.  Galectin-7 in Epithelial Homeostasis and Carcinomas.

Authors:  Tamara Advedissian; Frédérique Deshayes; Mireille Viguier
Journal:  Int J Mol Sci       Date:  2017-12-19       Impact factor: 5.923

7.  Prototype and Chimera-Type Galectins in Placentas with Spontaneous and Recurrent Miscarriages.

Authors:  Laura Unverdorben; Thomas Haufe; Laura Santoso; Simone Hofmann; Udo Jeschke; Stefan Hutter
Journal:  Int J Mol Sci       Date:  2016-04-28       Impact factor: 5.923

8.  Design of a peptidic inhibitor that targets the dimer interface of a prototypic galectin.

Authors:  Maria Claudia Vladoiu; Marilyne Labrie; Myriam Létourneau; Philippe Egesborg; Donald Gagné; Étienne Billard; Andrée-Anne Grosset; Nicolas Doucet; David Chatenet; Yves St-Pierre
Journal:  Oncotarget       Date:  2015-12-01

9.  High expression of galectin-7 associates with poor overall survival in patients with non-metastatic clear-cell renal cell carcinoma.

Authors:  Jieti Wang; Yidong Liu; Yuanfeng Yang; Zhiying Xu; Guodong Zhang; Zheng Liu; Hangcheng Fu; Zewei Wang; Haiou Liu; Jiejie Xu
Journal:  Oncotarget       Date:  2016-07-05

10.  In "High-Risk" Infants with Sufficient Vitamin D Status at Birth, Infant Vitamin D Supplementation Had No Effect on Allergy Outcomes: A Randomized Controlled Trial.

Authors:  Kristina Rueter; Anderson P Jones; Aris Siafarikas; Ee-Mun Lim; Susan L Prescott; Debra J Palmer
Journal:  Nutrients       Date:  2020-06-11       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.